Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03873701|
Recruitment Status : Completed
First Posted : March 13, 2019
Last Update Posted : April 25, 2019
The aim of this study is to evaluate the accuracy and implications of the diagnoses and treatment determined by bedside ultrasonography (b-US) of the kidneys compared to current clinical assessment. Potentially diagnosing patients faster and avoiding missing conditions leading to readmission or unnecessary radiation from computed tomography (CT).
This study evaluates the use of b-US as a supplement to clinical evaluation, in an unselected group of patients in the emergency department (ED) with signs of kidney involvement. The b-US of the kidneys is performed by a medical student certified in this technique. The evaluation will be based on data collected from a Danish hospital (Odense University Hospital, OUH) in autumn 2018.
|Condition or disease||Intervention/treatment|
|Hydronephrosis Pyelonephritis Urosepsis||Diagnostic Test: bedside ultrasonography|
|Study Type :||Observational|
|Actual Enrollment :||153 participants|
|Official Title:||Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement|
|Actual Study Start Date :||November 2, 2018|
|Actual Primary Completion Date :||April 5, 2019|
|Actual Study Completion Date :||April 8, 2019|
- Diagnostic Test: bedside ultrasonography
Patients suspicious to urinary tract infection with kidney involvement are being examined by ultrasonography to detect hydroneprhosis. The treating clinicians fill out questionnaires to validate the impact of the bedside ultrasonography on the patient care and treatment.Other Name: Ultrasound
- Ultrasonographic hydronephrosis [ Time Frame: All included patient undergo bedside ultrasonography within 4 hours after admission ]Ultrasonographic hydronephrosis defined by > 1cm pelvic dilation
- Clinical consequence of bedside ultrasonographic result [ Time Frame: Within 4 hours after admission ]Clinicians responsible for the primary clinical assessment determine treatment and further examinations before and after the ultrasonographic results.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03873701
|Odense C, Denmark, 5000|
|Study Director:||Annmarie T Lassen, Professor||Forskningsenheden FAM OUH|